Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where procedure options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our Pipeline We're https://financefeeds.com/colt-expands-u-s-network-with-new-transatlantic-route/